State Street Corp Acquires 77,506 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

State Street Corp grew its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 9.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 907,607 shares of the medical instruments supplier's stock after acquiring an additional 77,506 shares during the quarter. State Street Corp owned about 3.71% of ICU Medical worth $165,384,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. SG Americas Securities LLC boosted its stake in ICU Medical by 441.7% during the 2nd quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier's stock valued at $691,000 after purchasing an additional 4,744 shares during the last quarter. LMR Partners LLP purchased a new stake in shares of ICU Medical during the third quarter valued at $3,884,000. Savant Capital LLC bought a new stake in ICU Medical in the 2nd quarter worth about $431,000. First Eagle Investment Management LLC purchased a new position in ICU Medical in the 2nd quarter worth about $3,479,000. Finally, MetLife Investment Management LLC raised its position in ICU Medical by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 12,389 shares of the medical instruments supplier's stock worth $2,258,000 after buying an additional 6,981 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently commented on the stock. Raymond James lifted their price target on shares of ICU Medical from $158.00 to $190.00 and gave the stock an "outperform" rating in a research note on Thursday, September 12th. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday, November 20th. Jefferies Financial Group upgraded shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price for the company in a research note on Wednesday. KeyCorp raised their price target on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 13th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $177.25.

Insider Transactions at ICU Medical

In related news, CEO Vivek Jain sold 12,000 shares of the business's stock in a transaction that occurred on Friday, November 1st. The stock was sold at an average price of $171.84, for a total transaction of $2,062,080.00. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $17,973,261.12. The trade was a 10.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Christian B. Voigtlander sold 1,962 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $169.08, for a total transaction of $331,734.96. The disclosure for this sale can be found here. Insiders sold 40,364 shares of company stock worth $6,869,878 in the last three months. Corporate insiders own 6.70% of the company's stock.

ICU Medical Stock Performance

ICUI stock traded down $3.95 during midday trading on Friday, reaching $161.64. 167,092 shares of the company's stock traded hands, compared to its average volume of 271,012. The stock's 50-day moving average is $171.12 and its 200 day moving average is $150.98. The stock has a market cap of $3.96 billion, a P/E ratio of -35.37 and a beta of 0.62. ICU Medical, Inc. has a 52-week low of $86.80 and a 52-week high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.